Wong VWS, et al. - An inquiry was set up with regard to the long-term outcome after cessation of antiviral therapy in immune-tolerant chronic hepatitis B patients. Data brought to light the fact that rapid virological relapse was universal and clinical relapse was common after stopping antiviral therapy in patients with immune-tolerant chronic hepatitis B. Despite treatment reinitiation, HBeAg seroconversion appeared to be rare.